Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse Ataxin 1 ELISA Kit (AC2833)
Cat.#: ASET-1422
Specifications
Description Mouse Ataxin 1 ELISA Kit allows for the in vitro quantitative determination of mouse Ataxin 1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.375 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 15.625-1000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1294 Rat beta Arrestin 1 ELISA Kit (AC2705) Quantitative inquiry ASET-1959 Sheep TSH ELISA Kit (AC3370) Quantitative inquiry ASET-2188 Human ProSAAS ELISA Kit (AC3599) Quantitative inquiry ASET-1527 Mouse Neuropeptide Y ELISA Kit (AC2938) Quantitative inquiry ASET-1049 Mouse Proinsulin ELISA Kit (AC2460) Quantitative inquiry ASET-1012 Human KCNIP4 ELISA Kit (AC2423) Quantitative inquiry ASET-2105 Human GRK2 ELISA Kit (AC3516) Quantitative inquiry ASET-1408 Horse Luteinizing Hormone ELISA Kit (AC2819) Quantitative inquiry ASET-1409 Rat SLC26A4 ELISA Kit (AC2820) Quantitative inquiry ASET-1407 Human BMAL1 ELISA Kit (AC2818) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket